Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Phantom X EMG Sensor Implant for Upper-Limb Prosthesis Control

Official title: Clinical Evaluation of System for Bionic Arm Gesture Control (CYBORG)

Run by Phantom Neuro Inc. · NCT07325708 · Data updated 2026-11-12

This trial tests a small implanted EMG sensor array to help people with below-elbow amputations control a myoelectric prosthetic hand.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorPhantom Neuro Inc.
Industry-sponsored
Locations2 sites (Malvern, Victoria and 1 other locations)
StatusRecruiting
StartedApril 17, 2026
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedJune 24, 2026
Trial IDNCT07325708 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with unilateral transradial or wrist-disarticulation amputation who currently use or are candidates for a myoelectric prosthesis and are suitable for implantation.

Probably not a fit

Individuals unable to initiate substantial muscle contractions, with cognitive impairment, or with conditions that pose heightened surgical risk may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This first-in-human study evaluates the Phantom X Implantable EMG Sensor System in adults with unilateral transradial or wrist-disarticulation amputations. It is a prospective, single-arm, open-label feasibility trial examining surgical feasibility, device function, signal quality, and intuitive prosthetic control during functional tasks. Participants receive the implanted sensor array and telemetry module, activate and calibrate the system, then use a compatible prosthetic hand with periodic assessments of performance and safety. Outcomes include functional measures, device-related safety, and patient-reported quality of life and user experience.

Why it matters

Potential benefit: If successful, the approach could improve intuitive control and satisfaction with myoelectric prostheses for upper-limb amputees.

How similar studies have gone: Prior similar exploratory efforts in myoelectric interfaces have shown promise for improved control, but this specific implantable phantom X system is novel in humans.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient has a unilateral upper-limb difference (congenital or acquired) at the transradial or wrist level.
2. The patient currently uses a myoelectric prosthesis or is deemed a suitable candidate for fitting with a myoelectric prosthesis.
3. Patient is a suitable candidate for the implantation of the Phantom X sensor array as assessed by the implanting physician.
4. Patient is at least 18 years old and can provide written informed consent.
5. Patient is willing to comply with study protocol and make required study visits.
6. Patient received amputation ≥ 12 months prior to consent.

Exclusion Criteria:

1. Patient has a significant cognitive deficit resulting in inability to follow study directions.
2. Patient has a neuro-muscular deficit and is unable to initiate substantial muscle contraction in the residual limb as determined by the implanting physician or investigator.
3. Patient has another medical condition, which, in the opinion of the Investigator, may cause him/her to be non-compliant with the protocol, confound the data interpretation, or is associated with a life expectancy insufficient to allow for the completion of study procedures and follow-up.
4. The patient has a planned medical procedure (e.g., surgery) during the study period that could interfere with compliance with study visits or assessments.
5. Patient has an allergy to anesthesia or other medication used for sedation in the study.
6. Patient has an active implantable device (e.g. cardiac pacemaker, neuromodulation device) that can potentially interfere with the performance of Phantom X system.
7. Patient may require an MRI during the study duration.
8. Implantation of the device poses a health risk to the patient as determined by the implanting physician.
9. Women who are breastfeeding, currently pregnant or planning to become pregnant during the duration of the study or have a positive urine pregnancy test at screening.

Where it's running

  • Cabrini Health Ltd
    Malvern, Victoria, Australia
    Recruiting
  • ProMotion Prosthetics Pty Ltd
    Moorabbin, Victoria, Australia
    Recruiting

Study contacts

  • Principal investigator: Michael Lo, MBBS, FRACS, BSc (Hons) — Cabrini Private Hospital, Malvern, Australia
  • Study coordinator: Vinod Sharma, PhD
  • Email: vinod@phantomneuro.com
  • Phone: +1 512-763-0152

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.